To examine potential glycosylation on SERPINA1, we treated plasma proteins obtained from PC patients and a commercially available recombinant human SERPINA1 protein (derived from a mouse myeloma cell line NS0) with PNGase F to eliminate glycan. Here, NGLY1 is linked to plasma cell myeloma.